How does toxoplasmosis affect the maternal-foetal immune interface and pregnancy?

Parasite Immunol. 2019 Mar;41(3):e12606. doi: 10.1111/pim.12606. Epub 2018 Dec 19.

Abstract

Toxoplasma gondii is a zoonotic parasite which, depending on the geographical location, can infect between 10% and 90% of humans. Infection during pregnancy may result in congenital toxoplasmosis. The effects on the foetus vary depending on the stage of gestation in which primary maternal infection arises. A large body of research has focused on understanding immune response to toxoplasmosis, although few studies have addressed how it is affected by pregnancy or the pathological consequences of infection at the maternal-foetal interface. There is a lack of knowledge about how maternal immune cells, specifically macrophages, are modulated during infection and the resulting consequences for parasite control and pathology. Herein, we discuss the potential of T. gondii infection to affect the maternal-foetal interface and the potential of pregnancy to disrupt maternal immunity to T. gondii infection.

Keywords: activated-macrophage; congenital toxoplasmosis; immunopathogenesis; maternal-foetal Interface; pregnancy; zoonosis.

Publication types

  • Review

MeSH terms

  • Animals
  • Female
  • Fetus / immunology
  • Humans
  • Macrophages / immunology
  • Maternal-Fetal Relations / physiology*
  • Pregnancy
  • Pregnancy Complications, Parasitic / immunology*
  • Pregnancy Complications, Parasitic / parasitology
  • Toxoplasma / immunology*
  • Toxoplasmosis / immunology*
  • Toxoplasmosis / parasitology